US Blood Transfusion Diagnostics Market: Enhanced Screening Technologies Supporting Market Expansion

4 min read4 days ago

The US Blood Transfusion Diagnostics Market Size sector reached a market value of USD 1.91 billion in 2021. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 7.2% from 2021 to 2029. This trend is expected to culminate in a market value of USD 3.58 billion by 2029, offering significant growth opportunities in this rapidly expanding industry. North America led the market in 2021.

Request a Free Sample PDF Brochure of US Blood Transfusion Diagnostics Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/107024

In its latest study, Fortune Business Insights offers an in-depth analysis of the global US Blood Transfusion Diagnostics Market for the forecast period of 2024–2032. The report highlights key drivers, challenges, opportunities, and market trends. Additionally, the report provides market share insights expressed in both value and volume for the various segments.

Top Companies in the US Blood Transfusion Diagnostics Market:

QUOTIENT LIMITED (Switzerland)
Grifols, S.A. (Spain)
Immucor, Inc. (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Merck KGaA (Germany)
Beckman Coulter, Inc. (Danaher) (U.S.)
QuidelOrtho Corporation (U.S.)
F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott (U.S.)

The US Blood Transfusion Diagnostics Market report identifies major regions, including North America, Latin America, Europe, East Asia, and Japan, along with the most significant contributors from these regions. It includes detailed information on each key market player, including SWOT analysis, market data, market share, revenue, pricing, and gross margin.

US Blood Transfusion Diagnostics Market Market Dynamics:

Technological Advancements: Continuous advancements in blood transfusion diagnostics drive innovation in the US market, with new technologies such as nucleic acid testing (NAT), immunoassays, and automation enhancing the speed, accuracy, and safety of blood screening and compatibility testing.
Emphasis on Blood Safety: The market experiences growth due to increased emphasis on blood safety measures, including screening for infectious diseases such as HIV, hepatitis, and Zika virus, as well as implementation of pathogen reduction technologies to minimize the risk of transfusion-transmitted infections.
Rising Demand for Blood Products: Growing demand for blood products, including red blood cells, platelets, and plasma, in healthcare settings drives demand for blood transfusion diagnostics, ensuring compatibility, quality, and safety of blood products for transfusion recipients.
Regulatory Compliance and Standardization: Compliance with regulatory requirements, including FDA regulations, AABB standards, and CLIA certification, influences the development and adoption of blood transfusion diagnostics, ensuring adherence to quality assurance, validation, and proficiency testing protocols.
Market Consolidation and Competitive Landscape: The US blood transfusion diagnostics market is characterized by a competitive landscape with key players engaging in mergers, acquisitions, and strategic partnerships to expand product portfolios, geographic reach, and market share, driving competition and innovation in the industry.

Speak to an Analyst for Queries: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/107024

Insights for each vendor include:

Company profile
SWOT analysis
Key market information
Market share
Revenue, pricing, and gross margin

Key Insights from the US Blood Transfusion Diagnostics Market Research Report:

Macro- and microeconomic factors influencing the growth of US Blood Transfusion Diagnostics Market.
Comprehensive overview of US Blood Transfusion Diagnostics Market, including market definition, classification, and applications.
Analysis of major players based on mergers & acquisitions, R&D activities, and product launches.
Adoption trends of US Blood Transfusion Diagnostics Market across different industries.
Regions and countries with the highest potential for US Blood Transfusion Diagnostics Market stakeholders.

Regions Covered in the US Blood Transfusion Diagnostics Market Report:

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa

Frequently Asked Questions (FAQ’s)

What is the market size of US Blood Transfusion Diagnostics Market?
What factors are driving US Blood Transfusion Diagnostics Market growth in North America?
Who are the major players in the US Blood Transfusion Diagnostics Market?

About Us:

Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.

Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve sustainable growth. Our experienced analysts and consultants use leading research methodologies to provide comprehensive market assessments enriched with relevant data.

At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and recommendations that help them navigate technological and market changes. Our consulting services are designed to help companies uncover hidden opportunities and address competitive challenges.

Contact us:

Fortune Business Insights™ Pvt.

Phone: USA: +1 833 909 2966 (Toll-Free),

United Kingdom: +44 808 502 0280 (Toll-Free),

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com